- Filed
- Feb 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jun 4, 2024 | 39.94M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $0 |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $0 |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $0 |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $320K |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $320K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $888.45K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $882.32K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $888.45K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $882.32K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $0 |
| Current Assets | Q1 2024 · Dec 31, 2023 | $0 |
| Total Assets | Q1 2024 · Mar 31, 2024 | $142.46K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $178.16K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 39.3M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$48.76K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$479.41K |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$428.37K |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $333.29K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$458.04K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$338.85K |